“…As described in this section, it is well-established that the anticholinergic effects of first and second generation antipsychotics, and clozapine in particular, contribute to and compound GI motility issues such as constipation and bowel obstruction. Interestingly, while there exists substantial GI comorbidities in schizophrenia, the reverse may also be true, as increasingly psychiatric comorbidities are being reported in individuals with GI disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and celiac disease [36][37][38][39][40]. In this section, we review the motility effects of psychiatric medications, appraise current information regarding GI inflammation in schizophrenia as an inherent disease pathology and examine the overlapping epidemiology of the autoimmune disorder, celiac disease, and other dietary-based sensitivities with schizophrenia.…”